MedPath

The patient-reported outcome of postoperative Prostaglandin E1 derivative in Lumbar spine surgery: a randomized, double-blinded, controlled trial

Phase 4
Conditions
Postoperative leg numbness
Prostaglandin E1 derivative
Lumbar spine surgery
Postoperative outcome
Patient reported outcome
Registration Number
TCTR20201010003
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
60
Inclusion Criteria

1.Degenerative lumbar spine disease patients
2.patients who have to undergo lumbar spine surgery (1-2 levels)
3.leg numbness confirmed by Semmes-Weinstein monofilament test
4.age 18-70 years

Exclusion Criteria

1.patients with Lumbar spine disease not caused by denerative disease
2.patients with history of previous Lumbar spine surgery
3.Patients with peripheral vascular disease
4.Pregnancy or Breastfeeding patients
5.Patients who cannot be regular followed up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eg numbness 12 week Visual analog scale
Secondary Outcome Measures
NameTimeMethod
Back pain, leg pain 12 week Visual analog scale
© Copyright 2025. All Rights Reserved by MedPath